Merck & Co. said it is reorganizing its Human Health business into an Oncology Business Unit and a Specialty, Pharma & Infectious Diseases Business Unit. Jannie Oosthuizen was appointed executive vice president and president, Oncology and MSD International, and Brian Foard will join as executive vice president and president, Specialty, Pharma & Infectious Diseases, effective March 2. Both will report to CEO Robert M. Davis and join the executive team. Merck also named Chirfi Guindo executive vice president, Strategic Access, Policy & Communications, and he will remain on the executive team.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Merck & Co. Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 20260223251606) on February 23, 2026, and is solely responsible for the information contained therein.